New drug shows promise for Women's fibroid pain and bleeding
NCT ID NCT05445167
Summary
This Phase 3 study tested whether the drug KLH-2109 is better than a placebo at reducing heavy menstrual bleeding and pain in women with uterine fibroids. The trial involved 89 premenopausal Japanese women who experienced these symptoms. Researchers measured changes in bleeding and pain scores over several weeks to see if the drug provided effective symptom control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE FIBROIDS (MESH HEADING: LEIOMYOMA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Research Site
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.